## Abstract Although ataxia is the most distressing manifestation of Machado‐Joseph disease (MJD), little is known about its natural history. Therefore, we prospectively followed a cohort of patients with MJD for 13 months to characterize the progression of ataxia and identify its contributory fact
Prospective study of peripheral neuropathy in Machado–Joseph disease
✍ Scribed by Marcondes C. França Jr.; Anelyssa D'abreu; Anamarli Nucci; Fernando Cendes; Iscia Lopes-Cendes
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 118 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We report on a patient with genetically proven Machado‐Joseph Disease (MJD) presenting with signs indistinguishable from Parkinson's disease (PD), including levodopa response and typical levodopa‐induced motor fluctuations. Only after 10 years of prolonged benefit from levodopa and diff
## Abstract We describe several families of African origin with SCA3/Machado‐Joseph disease gene expansions. In these cases, the phenotype ranges from ataxia with parkinsonian signs to a syndrome clinically almost indistinguishable from idiopathic, L‐dopa–responsive Parkinson's disease. In contrast
Peripheral neuropathy has been reported in association with chronic liver disease. However, the precise incidence, severity and characteristics of neuropathy, and the relationship of neuropathy to different etiologies of liver disease have not been defined. In this study, 58 patients with advanced l
An expanded and unstable CAG repeat in the coding region of the MJD1 gene is the mutation responsible for spinocerebellar ataxia 3/Machado-Joseph disease. In order to determine whether there was a higher degree of instability in affected regions, the size of the expanded CAG repeat was analyzed in d